Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shotblocker for injection pain in geriatric patients
NCT06956066Completed
- Sponsor
- Istanbul Medeniyet University
- Start
- Dec 2023
- Primary completion
- Nov 2024
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Istanbul Medeniyet University. Primary endpoint: Beck Anxiety Inventory up to 1 day. Started Dec 2023; status: completed.
Beyond the preview
Go deeper on NCT06956066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06956066.